Back to results
US 2019/0240373 A1Published application
Diagnostic composition for identifying amniotic fluid
AssigneeCommon Sense Ltd.
InventorsYifat Hershcovitz-Fundoiano, Vered Pardo-Yissar, Hadar Kessary-Shoham
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of medical diagnostics and more specifically, to identification of amniotic fluid.
Claims24
1-20. (canceled)
A composition comprising:
- at least one polymer selected from cellulose, a cellulose ester, or a copolymer thereof;
- a plasticizer, wherein the plasticizer has a molecular weight of less than or equal to 600 g/mol;
- a surfactant, wherein the surfactant is a poloxamer;
- an acid represented by a structural formula that includes a ring moiety selected from an unsubstituted or substituted C6-C14 aromatic ring moiety, an unsubstituted or substituted C3-C8 carbocyclic ring moiety, an unsubstituted or substituted 5- to 8-membered heterocyclic ring moiety having 1 to 4 heteroatoms selected from nitrogen, sulfur or oxygen, or an unsubstituted or substituted 5- to 14-membered heteroaromatic ring moiety having 1 to 4 heteroatoms selected from nitrogen, sulfur, or oxygen;
- an ion-balance reagent, wherein the ion-balance reagent is a quaternary amine;
- and
- an indicator agent.
4 more elements
A composition comprising:
- cellulose acetate and cellulose acetate butyrate;
- a plasticizer, wherein the plasticizer is triethyl citrate;
- a surfactant, wherein the surfactant is poloxamer 407;
- an acid, wherein the acid is salicylic acid;
- an ion-balance reagent, wherein the ion-balance reagent is tridodecylmethyl ammonium chloride;
- and
- an indicator agent, wherein the indicator agent is nitrazine yellow.
4 more elements
Dependencies are inferred from the claim text.